Hadebe, B.; Harry, L.; Gabela, L.; Nxasana, T.; Ndlovu, N.; Pillay, V.; Masikane, S.; Patel, M.; Mpanya, D.; Buccimaza, I.;
et al. Comparing 68Ga-Pentixafor,18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study. Cancers 2025, 17, 763.
https://doi.org/10.3390/cancers17050763
AMA Style
Hadebe B, Harry L, Gabela L, Nxasana T, Ndlovu N, Pillay V, Masikane S, Patel M, Mpanya D, Buccimaza I,
et al. Comparing 68Ga-Pentixafor,18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study. Cancers. 2025; 17(5):763.
https://doi.org/10.3390/cancers17050763
Chicago/Turabian Style
Hadebe, Bawinile, Lerwine Harry, Lerato Gabela, Thembelihle Nxasana, Nontobeko Ndlovu, Venesen Pillay, Siphelele Masikane, Maryam Patel, Dineo Mpanya, Ines Buccimaza,
and et al. 2025. "Comparing 68Ga-Pentixafor,18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study" Cancers 17, no. 5: 763.
https://doi.org/10.3390/cancers17050763
APA Style
Hadebe, B., Harry, L., Gabela, L., Nxasana, T., Ndlovu, N., Pillay, V., Masikane, S., Patel, M., Mpanya, D., Buccimaza, I., Msimang, M., Aldous, C., Sathekge, M., & Vorster, M.
(2025). Comparing 68Ga-Pentixafor,18F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study. Cancers, 17(5), 763.
https://doi.org/10.3390/cancers17050763
